OIG Reiterates a Core Message: Stark Compliance and Fair Market Value Alone Do Not Shield Against Anti-Kickback Statute Risk

Why It Matters

The FAQs signal that regulators will scrutinize the purpose and totality of remuneration, not just formal compliance, raising enforcement risk for hospitals, labs, and physicians. Providers must redesign compliance programs to address both statutes simultaneously.

Key Takeaways

• Stark compliance does not guarantee Anti‑Kickback safety
• Fair market value alone cannot satisfy AKS safe harbor
• Intent to induce referrals triggers AKS liability
• OIG stresses total‑circumstances review of arrangements

Pulse Analysis

The Office of Inspector General’s latest FAQs underscore a growing regulatory emphasis on the substance over the form of health‑care transactions. While Stark law and the Anti‑Kickback Statute have long co‑existed, they target different misconduct: Stark imposes strict liability for prohibited referrals, whereas AKS hinges on the intent to induce business. By separating the two, OIG reminds providers that meeting a Stark exception—such as offering non‑monetary benefits under 42 C.F.R. § 411.357(k)—does not automatically immunize the arrangement from AKS scrutiny. The agency’s sporting‑event ticket example illustrates how seemingly benign perks can still be viewed as inducements if the underlying purpose is referral‑driven.

Fair market value (FMV) analyses have become a cornerstone of safe‑harbor defenses, yet OIG’s FAQ #17 makes clear that FMV is merely one element among several required criteria, including commercial reasonableness and the absence of a referral motive. The guidance aligns with decades of OIG opinion that a transaction must satisfy *all* safe‑harbor conditions; a well‑documented FMV valuation cannot override evidence of intent to reward referrals. This nuanced stance pushes health‑care entities to adopt more robust documentation practices, ensuring that pricing, services, and compensation structures are defensible under both statutes.

For compliance officers, the practical takeaway is a shift toward holistic risk assessments. Programs should integrate Stark and AKS considerations, conduct intent‑focused reviews, and evaluate the totality of benefits offered to referral sources. Training must stress that even non‑monetary perks can be problematic, and FMV studies should be paired with clear commercial justifications. By aligning policies with OIG’s clarified expectations, providers can better mitigate enforcement exposure and protect revenue streams in an increasingly vigilant regulatory environment.